Pro Medicus Limited
PME
Rankning i aktier
#1597
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aktiekurs
$129.30
Marknadsvärde
$13.51B
Förändring (1 dag)
-0.17%
Förändring (1 år)
-30.83%
Land
AU
Handel Pro Medicus Limited (PME)
Kategori
Healthcare
Antal utestående aktier för Pro Medicus Limited (PME)
Antal utestående aktier per June 2026: 104.47M
Enligt de senaste finansiella rapporterna och aktiekursen för Pro Medicus Limited är det aktuella antalet utestående aktier 104.47M. I slutet av June 2024 hade företaget 104.44M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Pro Medicus Limited (PME) från 2000 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 104.47M | -0.01% |
| 2025 | 104.48M | 0.03% |
| 2024 | 104.44M | 0.03% |
| 2023 | 104.41M | 0.09% |
| 2022 | 104.31M | 0.14% |
| 2021 | 104.17M | 0.26% |
| 2020 | 103.90M | 0.31% |
| 2019 | 103.57M | 0.37% |
| 2018 | 103.19M | 0.69% |
| 2017 | 102.49M | 1.09% |
| 2016 | 101.38M | 1.11% |
| 2015 | 100.26M | 0.00% |
| 2014 | 100.26M | 0.92% |
| 2013 | 99.35M | -0.91% |
| 2012 | 100.26M | -0.02% |
| 2011 | 100.28M | 0.00% |
| 2010 | 100.28M | 0.00% |
| 2009 | 100.28M | 0.00% |
| 2008 | 100.28M | 0.26% |
| 2007 | 100.02M | 0.02% |
| 2006 | 100.00M | 0.00% |
| 2005 | 100.00M | 0.00% |
| 2004 | 100.00M | 0.00% |
| 2003 | 100.00M | 0.00% |
| 2002 | 100.00M | 0.00% |
| 2001 | 100.00M | 0.00% |
| 2000 | 100.00M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 453.00M | 333.62% |
US
|
|
| 205.38M | 96.59% |
US
|
|
| 179.92M | 72.22% |
US
|
|
| 129.98M | 24.42% |
US
|
|
| - | - |
US
|
